WVE vs. OSCR

Last updated Apr 2, 2026

Compare and contrast key facts about Wave Life Sciences Ltd. (WVE) and Oscar Health, Inc. (OSCR).

Performance

WVE vs. OSCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Wave Life Sciences Ltd. (WVE) and Oscar Health, Inc. (OSCR). The values are adjusted to include any dividend payments, if applicable.

WVE vs. OSCR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
WVE Wave Life Sciences Ltd.	-59.82%	37.43%	144.95%	-27.86%	122.93%	-69.34%
OSCR Oscar Health, Inc.	-18.37%	6.92%	46.89%	271.95%	-68.66%	-77.44%

Fundamentals

Market Cap WVE : $1.23B OSCR : $3.32B
EPS WVE : -$1.20 OSCR : -$1.64
PS Ratio WVE : 27.28 OSCR : 0.27
PB Ratio WVE : 2.37 OSCR : 3.40
Total Revenue (TTM) WVE : $42.73M OSCR : $11.70B
Gross Profit (TTM) WVE : $21.12M OSCR : $8.90B
EBITDA (TTM) WVE : -$206.29M OSCR : -$390.98M

Returns By Period

In the year-to-date period, WVE achieves a -59.82% return, which is significantly lower than OSCR's -18.37% return.

WVE

• 1D: -5.79%
• 1M: -50.69%
• YTD: -59.82%
• 6M: -2.84%
• 1Y: -11.76%
• 3Y*: 16.41%
• 5Y*: 2.32%
• 10Y*: -6.72%

OSCR

• 1D: 2.27%
• 1M: -16.09%
• YTD: -18.37%
• 6M: -37.94%
• 1Y: -9.56%
• 3Y*: 21.50%
• 5Y*: -14.70%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

WVE vs. OSCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WVE

WVE Risk / Return Rank: 45
WVE Sharpe Ratio Rank: 37
WVE Sortino Ratio Rank: 60
WVE Omega Ratio Rank: 65
WVE Calmar Ratio Rank: 34
WVE Martin Ratio Rank: 31

OSCR

OSCR Risk / Return Rank: 36
OSCR Sharpe Ratio Rank: 35
OSCR Sortino Ratio Rank: 39
OSCR Omega Ratio Rank: 38
OSCR Calmar Ratio Rank: 34
OSCR Martin Ratio Rank: 34

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WVE vs. OSCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Wave Life Sciences Ltd. (WVE) and Oscar Health, Inc. (OSCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	WVE	OSCR	Difference
Sharpe ratio Return per unit of total volatility	-0.07	-0.12	+0.05
Sortino ratio Return per unit of downside risk	1.23	0.43	+0.81
Omega ratio Gain probability vs. loss probability	1.19	1.05	+0.14
Calmar ratio Return relative to maximum drawdown	-0.22	-0.20	-0.01
Martin ratio Return relative to average drawdown	-0.58	-0.39	-0.18
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

WVE vs. OSCR - Sharpe Ratio Comparison

The current WVE Sharpe Ratio is -0.07, which is higher than the OSCR Sharpe Ratio of -0.12. The chart below compares the historical Sharpe Ratios of WVE and OSCR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	WVE	OSCR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.07	-0.12	+0.05
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.02	-0.18	+0.20
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.07	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.08	-0.24	+0.16

Correlation

The correlation between WVE and OSCR is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

WVE vs. OSCR - Dividend Comparison

Neither WVE nor OSCR has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

WVE vs. OSCR - Drawdown Comparison

The maximum WVE drawdown since its inception was -97.77%, roughly equal to the maximum OSCR drawdown of -94.15%. Use the drawdown chart below to compare losses from any high point for WVE and OSCR.

Drawdown Indicators

	WVE	OSCR	Difference
Max Drawdown Largest peak-to-trough decline	-97.77%	-94.15%	-3.62%
Max Drawdown (1Y) Largest decline over 1 year	-70.91%	-51.71%	-19.20%
Max Drawdown (5Y) Largest decline over 5 years	-83.53%	-92.65%	+9.12%
Max Drawdown (10Y) Largest decline over 10 years	-97.77%	—	—
Current Drawdown Current decline from peak	-87.63%	-68.10%	-19.53%
Average Drawdown Average peak-to-trough decline	-64.38%	-65.77%	+1.39%
Ulcer Index Depth and duration of drawdowns from previous peaks	26.83%	26.69%	+0.14%

Volatility

WVE vs. OSCR - Volatility Comparison

Wave Life Sciences Ltd. (WVE) has a higher volatility of 70.82% compared to Oscar Health, Inc. (OSCR) at 17.53%. This indicates that WVE's price experiences larger fluctuations and is considered to be riskier than OSCR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	WVE	OSCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	70.82%	17.53%	+53.29%
Volatility (6M) Calculated over the trailing 6-month period	124.85%	52.18%	+72.67%
Volatility (1Y) Calculated over the trailing 1-year period	171.03%	80.57%	+90.46%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	114.63%	80.15%	+34.48%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	98.93%	80.05%	+18.88%

Financials